variants of unknown significance
Genetic Testing Challenges in Oncology: BRCA1 Variant Downgraded After Risk-Reducing Surgery
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
A recent JAMA study underscores racial disparities in genetic test access, which UPenn's Basser Center aims to address through its Black &Â BRCAÂ initiative.
BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions
Researchers reclassified 86 percent of variants initially determined to be VUS, potentially changing surveillance or treatment approaches for patients.
Genetic Testing Challenges in Oncology: Woman Without High Breast Cancer Risk Recommended Surgery
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
Genetic Testing Challenges in Oncology: BRCA2-Positive Healthy Young Man Recommended Mastectomy
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.